ArticleCureus2024
Comparative Analysis of Vitamin D, Folic Acid, and Antioxidant Minerals in Various Stages of Lung Cancer.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLung cancer continues to be one of the most common causes of death due to lung malignancies globally. Emerging research suggests that vitamins and trace minerals, particularly antioxidants, may play a role in cancer progression and treatment outcomes. This study conducts a comparative analysis of vitamin D, folic acid, and trace minerals (copper, zinc, and magnesium) in various stages of lung cancer patients.
methodsA cross-sectional study was conducted with 160 lung cancer patients, categorized into four stages (Stage 1 to Stage 4). Standardized biochemical assays, such as chemiluminescent immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), and atomic absorption spectroscopy (AAS), were used to measure the levels of vitamin D, folic acid, copper (Cu), zinc (Zn), and magnesium (Mg) in the blood. The nutrient levels were compared across stages to investigate any significant variations.
resultsVitamin D levels decreased significantly as lung cancer progressed, with Stage 1 showing the highest mean level (33 ng/mL) and Stage 4 the lowest (8 ng/mL). Folic acid levels fluctuated, showing a general decrease in the advanced stages, with some variations in the intermediate stages. Copper levels showed individual variability without a consistent trend across stages. Zinc levels were higher in early-stage patients and decreased as cancer progressed. Magnesium levels remained relatively stable across all stages.
conclusionThis comparative analysis highlights the potential significance of monitoring vitamin D, folic acid, and trace minerals in lung cancer patients across different stages. The results suggest that these nutrients may play a role in the progression of lung cancer and could serve as biomarkers for disease staging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.